Once again... Not only are these studies being promoted by Ivermectin pimps fabricated. Many on based on fake data where not a single patient was involved in the study -- these clowns made the entire study up -- In other words the entire study is imaginary.
As noted in the articles below -- it has reach the point where it is clear that science is vulnerable to complete fraud and it is time to take firms measures to stop the abuse of science from Ivermectin and Hydroxychloroquine fraudsters.
Let's take a look at some further information on this situation below...
Huge study supporting ivermectin as Covid treatment withdrawn over ethical concerns
The preprint endorsing ivermectin as a coronavirus therapy has been widely cited, but independent researchers find glaring discrepancies in the data
https://www.theguardian.com/science...vid-treatment-withdrawn-over-ethical-concerns
Large Ivermectin Study Retracted
— Preprint publisher finds evidence of plagiarism, problems with raw data
https://www.medpagetoday.com/special-reports/exclusives/93658
No surprise here -- dozens of "studies" pimping Ivermectin are misleading and false. In fact just about every study pushing Ivermectin as beneficial for preventing or treating COVID-19 is fabricated nonsense.
Misleading clinical evidence and systematic reviews on ivermectin for COVID-19
https://ebm.bmj.com/content/early/2021/05/26/bmjebm-2021-111678
Yes... nearly every study showing Ivermectin is effective at preventing or treating COVID-19 is completely fraudulent.
Ivermectin COVID-19 Scandal Shows How Vulnerable Science Is to Fraud
https://www.sciencealert.com/iverme...ge-wake-up-call-for-fraud-in-covid-19-science
Let's see what the manufacturer of Ivermectin, Merck, has to say...
Merck Statement on Ivermectin use During the COVID-19 Pandemic
https://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/
KENILWORTH, N.J., Feb. 4, 2021 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today affirmed its position regarding use of ivermectin during the COVID-19 pandemic. Company scientists continue to carefully examine the findings of all available and emerging studies of ivermectin for the treatment of COVID-19 for evidence of efficacy and safety. It is important to note that, to-date, our analysis has identified:
- No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies;
- No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and;
- A concerning lack of safety data in the majority of studies.
We do not believe that the data available support the safety and efficacy of ivermectin beyond the doses and populations indicated in the regulatory agency-approved prescribing information.